Back to home

    Pfizer (Ondo Tokenized Stock)

    PFEON

    Evaluation Score

    Overall rating on a scale of 0-10

    RiskReturn
    06.110
    Risk Level:
    Medium
    Recommendation:Hold
    Evaluated:August 28, 2026 (v14)

    Dimension Breakdown

    Development Activity7.5
    Community Health1.5
    Tokenomics7.5
    Market & Use Case5.0
    Team & Governance7.5
    Security & Audits6.5

    AI Analysis

    Comprehensive evaluation of the token

    PFEON is a Real World Asset (RWA) structured product issued by Ondo Global Markets (BVI) Limited that provides on-chain economic exposure to Pfizer Inc. equity with reinvested total-return dividends. The project demonstrates solid operational cadence (7.5/10), featuring daily attestations verified by Ankura Trust Company, multi-chain deployment (Ethereum, BNB Smart Chain, Solana), and active integration across Ondo's infrastructure. Its tokenomics (7.5/10) reflect a fully-backed 1:1 model with zero dilution or emissions, supported by custodial broker-dealers under Swiss law (Team & Governance: 7.5/10). Security is rated 6.5/10 due to clean historical performance with no exploits, depegs, or severe drawdowns, though it lacks smart-contract-specific public audit reports and relies heavily on institutional counterparty trust. The token's primary weaknesses are its nonexistent token-specific community (1.5/10) and a relatively small market capitalization (~$3.5M) with thin on-chain liquidity (Market & Use Case: 5.0/10). No qualifying red-flag events or fraudulent characteristics were identified.

    Development Activity

    Code updates and developer engagement

    RiskReturn
    07.510

    Community Support

    Social media presence and community engagement

    RiskReturn
    01.510

    Tokenomics

    Supply, distribution, and utility

    RiskReturn
    07.510

    Market & Use Case

    Value proposition and competitive landscape

    RiskReturn
    05.010

    Team & Governance

    Team background and project governance

    RiskReturn
    07.510

    Security & Audits

    Security history and audit status

    RiskReturn
    06.510

    About Pfizer (Ondo Tokenized Stock) (PFEON)

    Pfizer (Ondo Tokenized Stock) (PFEON) is a real-world asset (RWA) token issued by Ondo Global Markets (BVI) Limited that provides on-chain economic exposure to the equity of Pfizer Inc. (NYSE: PFE). Deployed primarily on Ethereum, with additional presences on BNB Smart Chain and Solana, PFEON is structured as a tokenized financial instrument that mirrors the price performance and total-return dividend mechanics of the underlying stock. The token maintains a fully backed 1:1 supply model with no native emissions, inflationary mechanisms, or staking rewards.

    The underlying securities are held in custody by US-registered broker-dealers and national trust companies, supplemented by a collateral buffer. The asset functions under sales terms governed by Swiss law and incorporates daily independent reserve attestations verified by Ankura Trust Company alongside Chainlink price feeds. Ondo's tokenized stocks are designed for 24/7 transferability and can be utilized as collateral within supported decentralized finance integrations, available exclusively to non-US individual and institutional participants.

    Because PFEON is an issuer-managed structured derivative, it entails centralized counterparty and custodial risks. Tokenholders receive economic exposure rather than direct legal equity ownership, meaning holders possess no corporate voting rights or shareholder governance powers. Additionally, publicly available evaluation records note the absence of a dedicated smart-contract security audit report for the specific token contract, while on-chain activity remains constrained by a small market capitalization of approximately $3.5 million and relatively thin trading liquidity.

    Similar Rated Tokens